Abstract
It has now been accepted for several years that sigma (sigma) receptors exist in, at least, two distinct entities denoted sigma1 and sigma2. Previous electrophysiological studies from our laboratory have demonstrated that several selective sigma1 ligands potentiate the neuronal response to NMDA. The nonselective sigma1/sigma2 ligand DTG also potentiates the NMDA response. However, when DTG is administered at doses between 3 and 40 microg/kg, the increase of NMDA-induced activation turns to an epileptoid activity. Until recently, the physiological role of sigma2 receptors had been less studied due to the lack of selective sigma2 ligands. The goal of the present electrophysiological studies was to assess the effect of the intravenous administration of new selective sigma2 ligands on the neuronal response to NMDA in the CA3 region of the rat dorsal hippocampus. Lu 28-179 and BD 1008 potentiated dose-dependently the NMDA response and generated bell-shaped dose-response curves. These ligands failed to generate any epileptoid activity on their own but the subsequent administration of a low dose of a sigma1 agonist (JO-1784) induced an epileptoid activity. Interestingly, the potentiations of the NMDA response induced by Lu 28-179 or B...Continue Reading
References
Mar 1, 1992·Trends in Pharmacological Sciences·R QuirionD P Taylor
Apr 25, 1990·European Journal of Pharmacology·F P MonnetC De Montigny
Jun 21, 1990·European Journal of Pharmacology·F P MonnetC de Montigny
Dec 19, 1989·European Journal of Pharmacology·F J RomanJ L Junien
Apr 8, 1988·Science·T P SuJ H Jaffe
Apr 8, 1988·Science·K ZinnT Maniatis
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jun 6, 1995·European Journal of Pharmacology·W D BowenA E Jacobson
Mar 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·R BergeronG Debonnel
May 26, 1995·Journal of Medicinal Chemistry·J PerregaardC Sánchez
May 26, 1995·Journal of Medicinal Chemistry·E K MoltzenE Meier
Apr 1, 1994·Psychopharmacology·T MauriceT Nabeshima
Mar 1, 1995·Endocrinology·J D RamamoorthyV Ganapathy
Jun 15, 1994·European Journal of Pharmacology·S B HellewellW D Bowen
Nov 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M YamadaH Miyaji
Jul 1, 1994·Synapse·D J McCannT P Su
Jun 1, 1994·British Journal of Pharmacology·F P MonnetC de Montigny
Aug 24, 1993·European Journal of Pharmacology·R BergeronC De Montigny
Jan 26, 1993·European Journal of Pharmacology·J M WalkerF I Carroll
Jul 14, 1995·European Journal of Pharmacology·R R MatsumotoB R De Costa
Apr 1, 1996·Neuroscience·G DebonnelC De Montigny
Jan 1, 1996·Brain Research Bulletin·H SershenA Lajtha
May 1, 1961·Journal of Neurophysiology·E R KANDEL, W A SPENCER
Citations
Feb 13, 2001·Synapse·S Couture, G Debonnel
Oct 23, 2004·Synapse·Jordanna E Bermack, Guy Debonnel
Oct 3, 1998·Brain Research·X Liang, R Y Wang
Sep 6, 2001·Neuroscience Research·H UedaS Mita
Jul 10, 1999·Neuroscience Letters·S TokuyamaH Ueda
Jun 5, 2003·Alcohol·Leslie L Devaud
Jun 29, 1999·British Journal of Pharmacology·T MauriceT Nabeshima
Sep 14, 1999·British Journal of Pharmacology·R BergeronG Debonnel
Jul 6, 2000·Behavioural Pharmacology·C Sánchez, M Papp
Jan 12, 2010·Behavioural Brain Research·Aren van WaardeRudi A Dierckx
Sep 2, 2006·Pharmacology, Biochemistry, and Behavior·Tangui MauriceJulie Espallergues
Jun 10, 2015·Journal of Receptor and Signal Transduction Research·Colin G Rousseaux, Stephanie F Greene
Aug 29, 2013·Bioorganic & Medicinal Chemistry·Samuel D BanisterMichael Kassiou
Feb 9, 2000·Frontiers in Neuroendocrinology·N A Compagnone, S H Mellon
Mar 8, 2005·Journal of Pharmacological Sciences·Jordanna E Bermack, Guy Debonnel
Feb 14, 2006·Journal of Pharmacological Sciences·François P Monnet, Tangui Maurice
Dec 11, 1999·Japanese Journal of Pharmacology·T MauriceT Nabeshima
Oct 1, 2004·Journal of Neurophysiology·Trent R AndersonR David Andrew
Aug 3, 2005·Psychopharmacology·Cruz M CendánJosé M Baeyens